$VRSK

Beckles Kathy Card sold $395K of VRSK

Beckles Kathy Card (Chief Legal Officer) sold 2,020 shares of Verisk Analytics, Inc. (VRSK) at $195.49 ($0.39M total) on 2026-07-31.

Original reporting
SEC EDGAR · Beckles Kathy Card
Published Jul 31, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

Insider open-market sales can modestly affect sentiment, but without additional context (e.g., guidance change, investigation, or material contract), the trading signal is usually weak.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new fundamental information in the text.

03

What to watch

The article does not state whether the sale was part of a broader pattern, whether other insiders sold/bought, or whether the insider’s compensation/vesting schedule drove liquidity needs.

Relevance 4/10Novelty 3/10Timing: filed 2026-07-31 after-hours (16:08 ET)

Background

The article is an SEC Form 4 insider transaction disclosure for Verisk Analytics, filed on 2026-07-31.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Verisk Analytics COO sold 2,020 shares on 2026-07-31 at $195.49, totaling about $394,889, per a new Form 4 filing.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades quickly.

Evidence & confidence

The filing is primary-source and time-stamped, but insider sales are common and the article provides no accompanying company-specific catalyst, guidance, or legal/regulatory development.

Market effects

No clear sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or tax/estate planning rather than a bearish view, especially since the filing does not cite any negative company event.

Key entities

  • Verisk Analytics, Inc.

    Subject of the Form 4 insider sale by its Chief Legal Officer.

  • Beckles Kathy Card

    Chief Legal Officer who sold 2,020 shares on 2026-07-31.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer